A detailed history of Engineers Gate Manager LP transactions in 89bio, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 21,142 shares of ETNB stock, worth $166,176. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,142
Previous 30,743 31.23%
Holding current value
$166,176
Previous $246,000 36.59%
% of portfolio
0.0%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$7.36 - $9.66 $70,663 - $92,745
-9,601 Reduced 31.23%
21,142 $156,000
Q2 2024

Aug 14, 2024

BUY
$7.31 - $10.9 $145,520 - $216,986
19,907 Added 183.71%
30,743 $246,000
Q1 2024

May 15, 2024

SELL
$8.13 - $13.77 $35,568 - $60,243
-4,375 Reduced 28.76%
10,836 $126,000
Q4 2023

Feb 14, 2024

SELL
$6.66 - $16.03 $60,992 - $146,802
-9,158 Reduced 37.58%
15,211 $169,000
Q3 2023

Nov 14, 2023

BUY
$15.06 - $19.41 $366,997 - $473,002
24,369 New
24,369 $376,000

Others Institutions Holding ETNB

About 89bio, Inc.


  • Ticker ETNB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,484,500
  • Market Cap $365M
  • Description
  • 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...
More about ETNB
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.